Hodgkin lymphoma trials in Austria
2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Leoben, Linz
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00 - Phase 2/3Taking peopleA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Vienna
- Age
- Up to 25 years
- People
- 210 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00